These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9095790)
21. Continuing donepezil produces cognitive benefits in Alzheimer's. Bland P Practitioner; 2012 Apr; 256(1750):5. PubMed ID: 22792683 [No Abstract] [Full Text] [Related]
22. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874 [No Abstract] [Full Text] [Related]
23. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease. Starr JM J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206 [No Abstract] [Full Text] [Related]
24. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Crismon ML Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465 [TBL] [Abstract][Full Text] [Related]
25. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699 [TBL] [Abstract][Full Text] [Related]
26. Anticholinesterases in the treatment of Alzheimer's dementia--the first year's experience in Argyll & Clyde. Hughes A; Coulter F; Gillespie R; Livingston H; Phillips K; Quinn E; Rimmer E; Smith M; Walker A Health Bull (Edinb); 2000 Jan; 58(1):20-4. PubMed ID: 12813848 [TBL] [Abstract][Full Text] [Related]
28. [Recent development of anti-dementia drugs]. Hirai S No To Shinkei; 2001 Mar; 53(3):235-40. PubMed ID: 11296396 [No Abstract] [Full Text] [Related]
29. Measures to prevent Alzheimer's patients from discontinuing the use of cholinesterase inhibitors. Meguro K Psychogeriatrics; 2014 Sep; 14(3):210-1. PubMed ID: 25219960 [No Abstract] [Full Text] [Related]
30. Camptocormia in Alzheimer's disease: an association? Brucki S; Nitrini R Mov Disord; 2008 Jan; 23(1):156-7. PubMed ID: 17994583 [No Abstract] [Full Text] [Related]
33. The impact of journal advertisements on prescribers of cholinesterase inhibitors. Sauer J; Howard R Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061 [No Abstract] [Full Text] [Related]
34. [Acetylcholinesterase inhibitor. Helpful not just in Alzheimer dementia]. MMW Fortschr Med; 2002 Aug; 144(33-34):59. PubMed ID: 12380156 [No Abstract] [Full Text] [Related]
38. Advertisements for donepezil (Aricept) in the BMJ. Local committee has declined to approve NHS hospital prescription of donepezil. Wagner N BMJ; 1997 May; 314(7093):1555-6. PubMed ID: 9183223 [No Abstract] [Full Text] [Related]
40. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis. Harry RD; Zakzanis KK Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]